Cargando…

Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients

Duchenne muscular dystrophy (DMD) is a rare genetic disease due to dystrophin gene mutations which cause progressive weakness and muscle wasting. Circadian rhythm coordinates biological processes with the 24-h cycle and it plays a key role in maintaining muscle functions, both in animal models and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Rachele, Falzarano, Maria Sofia, Osman, Hana, Armaroli, Annarita, Scotton, Chiara, Mantuano, Paola, Boccanegra, Brigida, Cappellari, Ornella, Schwartz, Elena, Yuryev, Anton, Mercuri, Eugenio, Bertini, Enrico, D’Amico, Adele, Mora, Marina, Johansson, Camilla, Al-Khalili Szigyarto, Cristina, De Luca, Annamaria, Ferlini, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300012/ https://www.ncbi.nlm.nih.gov/pubmed/34305639 http://dx.doi.org/10.3389/fphys.2021.678974

Ejemplares similares

Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype
por: Brioschi, Simona, et al.
Publicado: (2012)

β-Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation
por: Mantuano, Paola, et al.
Publicado: (2021)

Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy
por: Boccanegra, Brigida, et al.
Publicado: (2023)

A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring
por: Rossi, Rachele, et al.
Publicado: (2023)

Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks
por: Boccanegra, Brigida, et al.
Publicado: (2020)

Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy
por: Mele, Antonietta, et al.
Publicado: (2021)

Humanizing the mdx mouse model of DMD: the long and the short of it
por: Yucel, Nora, et al.
Publicado: (2018)

“The Social Network” and Muscular Dystrophies: The Lesson Learnt about the Niche Environment as a Target for Therapeutic Strategies
por: Cappellari, Ornella, et al.
Publicado: (2020)

Ergogenic Effect of BCAAs and L-Alanine Supplementation: Proof-of-Concept Study in a Murine Model of Physiological Exercise
por: Mantuano, Paola, et al.
Publicado: (2020)

Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications
por: Mele, Antonietta, et al.
Publicado: (2023)

Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia
por: Mantuano, Paola, et al.
Publicado: (2023)

LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model
por: Boccanegra, Brigida, et al.
Publicado: (2023)

Author Correction: Humanizing the mdx mouse model of DMD: the long and the short of it
por: Yucel, Nora, et al.
Publicado: (2020)

The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms
por: Bovolenta, Matteo, et al.
Publicado: (2012)

Ventilatory Chemosensory Drive Is Blunted in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)
por: Mosqueira, Matias, et al.
Publicado: (2013)

Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmd(mdx) rat model
por: Caudal, Dorian, et al.
Publicado: (2020)

“Of Mice and Measures”: A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic: First Workshop Report: Examining current findings and opportunities around the emerging D2.B10-Dmd(mdx)/J (D2/mdx) model in context of the classic C57BL/10ScSn-Dmd(mdx)/J (Bl10/mdx)
por: Gordish-Dressman, Heather, et al.
Publicado: (2018)

Cardiovascular phenotype of the Dmd(mdx) rat – a suitable animal model for Duchenne muscular dystrophy
por: Szabó, Petra Lujza, et al.
Publicado: (2021)

Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD
por: Mázala, Davi A. G., et al.
Publicado: (2023)

Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD
por: Mázala, Davi A. G., et al.
Publicado: (2023)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Duchenne Muscular Dystrophy: From Diagnosis to Therapy
por: Falzarano, Maria Sofia, et al.
Publicado: (2015)

A novel DMD IRES results in a functional N-truncated dystrophin, providing a potential route to therapy for patients with 5’ mutations
por: Wein, Nicolas, et al.
Publicado: (2014)

Characterization of a rare case of Ullrich congenital muscular dystrophy due to truncating mutations within the COL6A1 gene C-Terminal domain: a case report
por: Martoni, Elena, et al.
Publicado: (2013)

Dasatinib/HP-β-CD Inclusion Complex Based Aqueous Formulation as a Promising Tool for the Treatment of Paediatric Neuromuscular Disorders
por: Cutrignelli, Annalisa, et al.
Publicado: (2019)

Upper Limb Changes in DMD Patients Amenable to Skipping Exons 44, 45, 51 and 53: A 24-Month Study
por: Brogna, Claudia, et al.
Publicado: (2023)

Myogenic Reprogramming of Bone Marrow Derived Cells in a W(41)Dmd(mdx) Deficient Mouse Model
por: Walsh, Stuart, et al.
Publicado: (2011)

Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse
por: Wang, Derek W., et al.
Publicado: (2018)

Hematopoietic Prostaglandin D Synthase Inhibitor PK007 Decreases Muscle Necrosis in DMD mdx Model Mice
por: Yarlagadda, Sai, et al.
Publicado: (2021)

Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study
por: Messina, Sonia, et al.
Publicado: (2016)

Characterization of the Cardiac Structure and Function of Conscious D2.B10-Dmd(mdx)/J (D2-mdx) mice from 16–17 to 24–25 Weeks of Age
por: De Giorgio, Daria, et al.
Publicado: (2023)

Recessive mutations in MSTO1 cause mitochondrial dynamics impairment, leading to myopathy and ataxia
por: Nasca, Alessia, et al.
Publicado: (2017)

Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
por: Fortunato, Fernanda, et al.
Publicado: (2021)

Dmd(mdx)/Large(myd): a new mouse model of neuromuscular diseases useful for studying physiopathological mechanisms and testing therapies
por: Martins, Poliana C. M., et al.
Publicado: (2013)

Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical–Experimental, and Real-World Evidence
por: Crisafulli, Salvatore, et al.
Publicado: (2023)

Serotonin and Histamine Therapy Increases Tetanic Forces of Myoblasts, Reduces Muscle Injury, and Improves Grip Strength Performance of Dmd(mdx) Mice
por: Gurel, Volkan, et al.
Publicado: (2015)

A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures
por: Hiller, Monika, et al.
Publicado: (2018)

DMD & BMD – CLINICAL: P.51 DMD Hub: demonstrating impact for DMD trials
por: Heslop, E., et al.
Publicado: (2020)

RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing
por: Falzarano, Maria S., et al.
Publicado: (2021)

Data on protein abundance alteration induced by chronic exercise in mdx mice model of Duchenne muscular dystrophy and potential modulation by apocynin and taurine
por: Gamberi, Tania, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qgt4sana93hie75k0drslsvo23